{
  "report_rows": [
    {
      "kpi": "Adjusted EPS (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$3.95 vs. cons $3.77",
      "confidence": "HIGH"
    },
    {
      "kpi": "Total Revenue (Q2 2026)",
      "prediction": "MISS",
      "answer": "pred ~$1.68B vs. cons $1.70B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Total Contract Value (CV) growth YoY, FX-neutral",
      "prediction": "MISS",
      "answer": "pred ~2.0% vs. cons/expected acceleration to ~3.0%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 Revenue guidance",
      "prediction": "LOWER",
      "answer": "guide ~$6.43B vs. cons $6.50B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 Adjusted EPS guidance",
      "prediction": "LOWER",
      "answer": "guide ~$13.45 vs. cons $13.65 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "CV growth reacceleration trajectory (qualitative H2'26/Fed-lap commentary)",
      "prediction": "UNKNOWN",
      "answer": "guide ~reiterated 'accelerate through 2026' vs. cons skepticism after 3 straight qtrs of deceleration 1.8%->-0.1%->0.4% (FY2026)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -6.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -9.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "Gartner has beaten headline EPS every quarter for a year yet the stock cratered -28% (Aug'25) and -21% (Feb'26) both times because CV growth/forward guidance disappointed; GTS CV has actually decelerated the last 3 quarters (1.8%->-0.1%->0.4%) despite management's repeated 'acceleration' promise and the explicit claim that the Fed headwind laps in Q2. If Q2 CV doesn't show real reacceleration, sell-side will trim FY26/FY27 CV, revenue and EPS-CAGR (12%+) models further in the days after the print (as happened post-Aug'25 and post-Feb'26, where the stock kept falling for ~1 week after the initial gap down before stabilizing), producing continued downside beyond the day-1 reaction even though the reported EPS itself beats.",
  "day5_confidence": "MEDIUM"
}